Interleukin-6 Receptor Inhibition With Tocilizumab and Attainment of Disease Remission in Rheumatoid Arthritis: The Role of Acute-Phase ReactantsSMOLEN, Josef S; ALETAHA, Daniel.Arthritis and rheumatism. 2011, Vol 63, Num 1, pp 43-52, issn 0004-3591, 10 p.Article

Ten years of infliximab: Insights from clinical trials in rheumatoid arthritisSMOLEN, Josef S.European journal of pharmacology. 2009, Vol 623, issn 0014-2999, S5-S9, NSArticle

Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. an observational studyALETAHA, Daniel; SMOLEN, Josef S.Journal of rheumatology. 2002, Vol 29, Num 8, pp 1631-1638, issn 0315-162XArticle

Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: Clinical evaluation and cost analysisALETAHA, Daniel; SMOLEN, Josef S.Arthritis care and research. 2002, Vol 47, Num 2, pp 181-188, issn 0893-7524Article

Forget personalised medicine and focus on abating disease activitySMOLEN, Josef S; ALETAHA, Daniel.Annals of the rheumatic diseases. 2013, Vol 72, Num 1, pp 3-6, issn 0003-4967, 4 p.Article

Joint Damage in Rheumatoid Arthritis Progresses in Remission According to the Disease Activity Score in 28 Joints and Is Driven by Residual Swollen JointsALETAHA, Daniel; SMOLEN, Josef S.Arthritis and rheumatism. 2011, Vol 63, Num 12, pp 3702-3711, issn 0004-3591, 10 p.Article

Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritisRADNER, Helga; SMOLEN, Josef S; ALETAHA, Daniel et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 2, pp 381-388, issn 1462-0324, 8 p.Article

Rheumatoid arthritis near remission: clinical rather than laboratory inflammation is associated with radiographic progressionALETAHA, Daniel; ALASTI, Farideh; SMOLEN, Josef S et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 11, pp 1975-1980, issn 0003-4967, 6 p.Article

Impact of comorbidity on physical function in patients with rheumatoid arthritisRADNER, Helga; SMOLEN, Josef S; ALETAHA, Daniel et al.Annals of the rheumatic diseases. 2010, Vol 69, Num 3, pp 536-541, issn 0003-4967, 6 p.Article

The Importance of Reporting Disease Activity States in Rheumatoid Arthritis Clinical TrialsALETAHA, Daniel; FUNOVITS, Julia; SMOLEN, Josef S et al.Arthritis and rheumatism. 2008, Vol 58, Num 9, pp 2622-2631, issn 0004-3591, 10 p.Article

Near misses of ACR/EULAR criteria for remission: effects of patient global assessment in Boolean and index-based definitionsSTUDENIC, Paul; SMOLEN, Josef S; ALETAHA, Daniel et al.Annals of the rheumatic diseases. 2012, Vol 71, Num 10, pp 1702-1705, issn 0003-4967, 4 p.Article

Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cellsSCHEINECKER, Clemens; BONELLI, Michael; SMOLEN, Josef S et al.Journal of autoimmunity (Print). 2010, Vol 35, Num 3, pp 269-275, issn 0896-8411, 7 p.Article

The evolution of the immunobiology of co-stimulatory pathways : clinical implicationsTRIKUDANATHAN, S; SAYEGH, M. H.Clinical and experimental rheumatology (Testo stampato). 2007, Vol 25, Num 5, issn 0392-856X, S12-S21, SUP46Article

Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritisBÖHLER, Christoph; RADNER, Helga; SMOLEN, Josef S et al.Annals of the rheumatic diseases. 2013, Vol 72, Num 2, pp 241-244, issn 0003-4967, 4 p.Article

Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysisSCHOELS, Monika; ALETAHA, Daniel; SMOLEN, Josef S et al.Annals of the rheumatic diseases. 2012, Vol 71, Num 8, pp 1303-1308, issn 0003-4967, 6 p.Article

Safety of T-cell co-stimulation modulation with abatacept in patients with rheumatoid arthritisSIBILIA, J; WESTHOVENS, R.Clinical and experimental rheumatology (Testo stampato). 2007, Vol 25, Num 5, issn 0392-856X, S46-S56, SUP46Article

Safety and efficacy of tumor necrosis factor a blockade in systemic lupus erythematosus: An open-label studyARINGER, Martin; GRANINGER, Winfried B; STEINER, Günter et al.Arthritis and rheumatism. 2004, Vol 50, Num 10, pp 3161-3169, issn 0004-3591, 9 p.Article

Reporting of long-term extension studies: lack of consistency calls for consensusBUCH, Maya H; ALETAHA, Daniel; EMERY, Paul et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 6, pp 886-890, issn 0003-4967, 5 p.Article

Quality of life in patients with rheumatoid arthritis : Does abatacept make a difference?MICHAUD, K; BOMBARDIER, C; EMERY, P et al.Clinical and experimental rheumatology (Testo stampato). 2007, Vol 25, Num 5, issn 0392-856X, S35-S45, SUP46Article

Disease activity measures for rheumatoid arthritisDOUGADOS, M; ALETAHA, D; VAN RIEL, P et al.Clinical and experimental rheumatology (Testo stampato). 2007, Vol 25, Num 5, issn 0392-856X, S22-S29, SUP46Article

Pro-inflammatory cytokines in rheumatoid arthritis : Pathogenetic and therapeutic aspectsSMOLEN, Josef S; REDLICH, Kurt; ZWERINA, Jochen et al.Clinical reviews in allergy and immunology. 2005, Vol 28, Num 3, pp 239-248, issn 1080-0549, 10 p.Article

Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activitySTUMMVOLL, Georg H; SCHMALDIENST, Sabine; SMOLEN, Josef S et al.Nephrology, dialysis, transplantation (Print). 2012, Vol 27, Num 2, pp 618-626, issn 0931-0509, 9 p.Article

Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trialsSMOLEN, Josef S; ALETAHA, Daniel; GRISAR, Johannes C et al.Annals of the rheumatic diseases. 2010, Vol 69, Num 6, pp 1058-1064, issn 0003-4967, 7 p.Article

Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity indexALETAHA, Daniel; MARTINEZ-AVILA, Jose; KVIEN, Tore K et al.Annals of the rheumatic diseases. 2012, Vol 71, Num 7, pp 1190-1196, issn 0003-4967, 7 p.Article

A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritisVASTESAEGER, Nathan; XU, Stephen; ALETAHA, Daniel et al.Rheumatology (Oxford. Print). 2009, Vol 48, Num 9, pp 1114-1121, issn 1462-0324, 8 p.Article